
Louisiana-Pacific Corporation (LPX) Q2 2026 Earnings Call Transcript
Louisiana-Pacific Corporation (LPX) Q2 2026 Earnings Call Transcript
Latest financial and economic news and analysis

Louisiana-Pacific Corporation (LPX) Q2 2026 Earnings Call Transcript

SmartRent, Inc. (SMRT) Q2 2026 Earnings Call Transcript

Greenlight Capital Re, Ltd. (GLRE) Q2 2026 Earnings Call Transcript

Delek Logistics Partners, LP Common Units (DKL) Q2 2026 Earnings Call Transcript

Spire Inc. (SR) Q3 2026 Earnings Call Transcript

USANA Health Sciences, Inc. (USNA) Q2 2026 Earnings Call Transcript

SUNNYVALE, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and report its financial results for the second quarter of 2026 by conference call on Wednesday, August 12, 2026 at 4:30 PM EDT. Following management's formal remarks, there will be a question-and-answer session.

CFRA's Keith Snyder says "there was a lot to like" in SpaceX (SPCX) earnings, but he points to a red flag in the company's capex spending levels. He also likes the "firm" computing power contracts SpaceX holds but he wants to hear if the company can grow "on its own without renting out excess capacity.

Some brokerages appeared optimistic about SpaceX's quarterly earnings: JPMorgan analysts, who lifted their price target for shares to $240 from $225, wrote SpaceX is benefiting from “extreme vertical integration” while noting its “pace of change in AI is incredibly fast,” and that a step-up in AI infrastructure and higher monetization could push SpaceX's AI revenue to $100 billion in 2027. Wells Fargo analysts cut their price target for SpaceX shares to $215 from $230 amid broader caution about its AI spending, noting that SpaceX was “off to an ambitious start” and that revenue projections for 2027 and 2028 were higher than expected, but so were capital expenditure estimates.

Subaru is upgraded to 'BUY' with a new price target of ¥2,600, citing recovery momentum and undervaluation. Management's cautious hybrid/ICE strategy, capital conservation, and share buybacks are favored over aggressive EV investment amid sector uncertainty. Tariffs, FX headwinds, and EV impairment charges have pressured margins, but normalized earnings yield above 8% and a 4.5% dividend yield underpin upside.

PRMB beats second-quarter earnings and sales estimates, fueled by spring and premium water, and raises its 2026 sales growth outlook.

Investors need to pay close attention to MSDL stock based on the movements in the options market lately.

TMDX's Q2 revenue beat and raised outlook are overshadowed by earnings miss, declining margins and sharply higher operating costs.

HWBK posts stronger second-quarter 2026 earnings as higher interest and non-interest income lift profitability, margins and efficiency.

NKE's performance-led strategy centers on innovation, athlete engagement and sport-focused execution to drive long-term growth despite near-term demand challenges.